RYN vs. OHI, CUBE, HR, RHP, SBRA, GEO, EPR, NHI, MPW, and PCH
Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Omega Healthcare Investors (OHI), CubeSmart (CUBE), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), Sabra Health Care REIT (SBRA), The GEO Group (GEO), EPR Properties (EPR), National Health Investors (NHI), Medical Properties Trust (MPW), and PotlatchDeltic (PCH). These companies are all part of the "specialized reits" industry.
Rayonier vs.
Rayonier (NYSE:RYN) and Omega Healthcare Investors (NYSE:OHI) are both construction companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, community ranking, media sentiment and analyst recommendations.
In the previous week, Omega Healthcare Investors had 7 more articles in the media than Rayonier. MarketBeat recorded 17 mentions for Omega Healthcare Investors and 10 mentions for Rayonier. Omega Healthcare Investors' average media sentiment score of 1.41 beat Rayonier's score of 1.22 indicating that Omega Healthcare Investors is being referred to more favorably in the news media.
Omega Healthcare Investors has lower revenue, but higher earnings than Rayonier. Rayonier is trading at a lower price-to-earnings ratio than Omega Healthcare Investors, indicating that it is currently the more affordable of the two stocks.
Rayonier currently has a consensus target price of $29.00, suggesting a potential upside of 17.93%. Omega Healthcare Investors has a consensus target price of $42.00, suggesting a potential upside of 10.99%. Given Rayonier's higher possible upside, equities analysts clearly believe Rayonier is more favorable than Omega Healthcare Investors.
Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.4%. Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 7.1%. Rayonier pays out 46.2% of its earnings in the form of a dividend. Omega Healthcare Investors pays out 172.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Rayonier has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Omega Healthcare Investors has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.
Omega Healthcare Investors received 143 more outperform votes than Rayonier when rated by MarketBeat users. Likewise, 57.70% of users gave Omega Healthcare Investors an outperform vote while only 54.40% of users gave Rayonier an outperform vote.
Omega Healthcare Investors has a net margin of 38.65% compared to Rayonier's net margin of 28.44%. Omega Healthcare Investors' return on equity of 9.71% beat Rayonier's return on equity.
89.1% of Rayonier shares are owned by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are owned by institutional investors. 0.8% of Rayonier shares are owned by company insiders. Comparatively, 1.4% of Omega Healthcare Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
Omega Healthcare Investors beats Rayonier on 14 of the 20 factors compared between the two stocks.
Get Rayonier News Delivered to You Automatically
Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Rayonier Competitors List
Related Companies and Tools
This page (NYSE:RYN) was last updated on 4/14/2025 by MarketBeat.com Staff